The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

PHASE3TerminatedINTERVENTIONAL
Enrollment

842

Participants

Timeline

Start Date

December 31, 2004

Study Completion Date

August 31, 2006

Conditions
Breast NeoplasmsNeoplasms, Hormone-Dependent
Interventions
DRUG

Atamestane

DRUG

Toremifene

DRUG

Letrozole

DRUG

Aromatase inhibition

DRUG

Estrogen receptor blocker

PROCEDURE

Hormone therapy

PROCEDURE

Endocrine therapy

PROCEDURE

Antiestrogen therapy

Trial Locations (104)

1233

Research Site, Sofia

1756

Research Site, Sofia

2700

Research Site, Blagoevgrad

4004

Research Site, Plovdiv

6003

Research Site, Stara Zagora

9010

Research Site, Varna

9700

Research Site, Shumen

10595

Research Site, Valhalla

11365

Research Site, Fresh Meadows

14029

Research Site, Chernihiv

19146

Research Site, Philadelphia

19611

Research Site, West Reading

21021

Research Site, Vinnitsa

21204

Research Site, Towson

22115

Research Site, Bucharest

22328

Research Site, Bucharest

23320

Research Site, Chesapeake

23502

Research Site, Norfolk

24541

Research Site, Danville

29009

Research Site, Khmelnitsky

29203

Research Site, Columbia

30901

Research Site, Augusta

31405

Research Site, Savannah

32209

Research Site, Jacksonville

33028

Research Site, Pembroke Pines

33176

Research Site, Miami

33607

Research Site, Tampa

34474

Research Site, Ocala

34741

Research Site, Kissimmee

36607

Research Site, Mobile

37620

Research Site, Bristol

38120

Research Site, Memphis

40005

Research Site, Sumy

40207

Research Site, Louisville

43018

Research Site, Lutsk

43701

Research Site, Zanesville

44691

Research Site, Wooster

46023

Research Site, Ternopil

47150

Research Site, New Albany

47713

Research Site, Evansville

48076

Research Site, Detroit

48532

Research Site, Flint

53215

Research Site, Milwaukee

53405

Research Site, Racine

54501

Research Site, Rhinelander

55422

Research Site, Robbinsdale

58013

Research Site, Chernivtsy

59101

Research Site, Billings

61024

Research Site, Kharkiv

63128

Research Site, St Louis

65025

Research Site, Odesa

66214

Research Site, Lenexa

71105

Research Site, Shreveport

71913

Research Site, Hot Springs

73000

Research Site, Kherson

77024

Research Site, Houston

77504

Research Site, Pasadena

79031

Research Site, Lviv

83092

Research Site, Donetsk

84403

Research Site, Ogden

85704

Research Site, Tuscon

87500

Research Site, Mariupol

89502

Research Site, Reno

90807

Research Site, Los Angeles

91047

Research Site, Luhansk

92064

Research Site, Poway

92708

Research Site, Fountain Valley

94904

Research Site, Greenbrae

98503

Research Site, Lacey

100337

Research Site, Ploieşti

119121

Research Site, Moscow

121356

Research Site, Moscow

150054

Research Site, Yaroslavl

163045

Research Site, Arkhanglsk

167904

Research Site, Syktyvkar

191104

Research Site, Saint Petersburg

197022

Research Site, Saint Petersburg

197758

Research Site, Saint Petersburg

236040

Research Site, Kaliningrad

248007

Research Site, Kaluga

300223

Research Site, Timișoara

302020

Research Site, Oryol

310017

Research Site, Arad

350040

Research site, Krasnodar

354057

Research Site, Sochi

357524

Research Site, Pyatigorsk

392013

Research Site, Tambov

400015

Research Site, Cluj-Napoca

410032

Research Site, Oradea

413115

Research Site, Engel's

414041

Research Site, Astrakhan

420012

Research Site, Kazan'

432063

Research Site, Ulyanovsk

450054

Research Site, Ufa

454087

Research Site, Chelyabinsk

460021

Research Site, Orenburg

500366

Research Site, Brasov

540141

Research Site, Târgu Mureş

614066

Research Site, Perm

644013

Research Site, Omsk

664035

Research Site, Irkutsk

06830

Research Site, Greenwich

08003

Research Site, Cherry Hill

07101

Research Site, Newark

Sponsors
All Listed Sponsors
lead

Intarcia Therapeutics

INDUSTRY